KRAS and neoplasm: This intercellular transfer induces intracellular heterogeneity of mutant KRAS in cells with endogenous wild-type KRAS. This finding has strong implications for the ability of TNTs and other modes of intercellular transfer to potentially reprogram malignant and stromal cells in the surrounding tumor microenvironment.